Please visit answersincme.com/GSN860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, experts in oncology and thoracic surgery discuss chemo-immunotherapeutic approaches in early-stage non–small cell lung cancer. Upon completion of this activity, participants should be better able to: Review the clinical profiles of available and emerging neoadjuvant and perioperative immunotherapy-based approaches for patients with early-stage NSCLC; Identify patients for whom a neoadjuvant or perioperative immunotherapy-based approach is warranted, based on the available and emerging clinical data; and Outline a multidisciplinary strategy to improve outcomes in early-stage NSCLC through the use of neoadjuvant or perioperative immunotherapy-based approaches in appropriate patients.